FDA gets to grips with pharmacogenomics:
This article was originally published in Clinica
Executive Summary
The US FDA wants to meet with officials from industry to learn about the demands involved in developing pharmacogenomic products. The agency will use the comments to help shape an upcoming guidance document on the topic. The day-long meeting at the Marriott Crystal Gateway Hotel in Arlington County, Virginia, will take place on July 29 from 8 am. Register by July 26, and submit comments by August 30. For more information, contact the meeting's co-sponsor, the Drug Information Association at email: [email protected]